TcrossGlobal

Efficacy and Safety of Edoxaban in Anticoagulant Therapy after Surgical Bioprosthetic Valve Replacement: The ENBALV Trial

The ENBALV trial demonstrated that edoxaban has shown potential as an alternative anticoagulant to warfarin in patients undergoing surgical valve replacement with a bioprosthetic aortic or mitral valve, according to a study presented by Dr. Chisato Izumi, National Cerebral and Cardiovascular Center, Japan, in the Late-Breaking Science session at AHA Scientific Sessions 2024.

Between May 2022 and January 2024, a total of 410 patients aged 18 to 85 years who underwent surgica...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.